<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20191030045274N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2020-01-11</date_registration>
      <primary_sponsor>Shahid Beheshti University of Medical Sciences</primary_sponsor>
      <public_title>Effect of biofeedback, psyllium and polyethylene glycol in treating constipation due to dyssynergia</public_title>
      <acronym></acronym>
      <scientific_title>Comparison of biofeedback, biofeedback plus fiber laxative, and biofeedback plus osmotic laxative for treatment of constipation in patients with pelvic floor dyssynergia</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2018-02-20</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>105</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/43367</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Single blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: In this study we used simple randomized allocation with random number table. All patients had equal chance of being placed in each group.The randomization unit was individualized and the random sequence was based on a random number table.Color, odor, drug form and biofeedback exercise were similar in all groups, Blinding description: n this single blinded study, all participants completed a written informed consent in one of the study groups and in order to avoid prejudice, the subjects were attempted to be as similar in shape, color and smell as possible.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Constipation due to pelvic floor dyssynergia.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: First group: Patients who are assigned to do biofeedback exercises and also receive 15 grams of psyllium powder twice daily for three weeks. Intervention 2: Intervention group: Second group:Patients who are assigned to do biofeedback exercises and also receive 10 grams of polethylene glycol twice daily for three weeks. Intervention 3: Control group:Patients who are assigned to do biofeedback exercises. Each patient receives one session of education which takes 1.5 hours. They will be taught relaxation of anal sphincter, better sensation of defecation and rectoanal coordination by rectal probe.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
All potential data could be shared after the patients are unidentified.

When:
Accessing the information will be 6 months after publishing the data.

To whom:
The data will be available to all researchers working in scientific and academic institutes.

Conditions:
The data will only be accessible by academic researchers for use in accredited scientific centers.

Where to obtain:
Dr. Mohammad Sadegh Jamashidi: sadegh.jamshidi@yahoo.com
mobile number: 00989123447508

How to obtain:
The applicant must provide complete information about the field of work, specialty, academic record, email, address and phone number.

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Habib Malekpour</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Shahid Madani St., Imam Hossein hospital</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1985711151</zip>
        <telephone>+98 21 7343 3000</telephone>
        <email>habib.malekpour@gmail.com</email>
        <affiliation>Shahid Beheshti University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Mohammad Sadegh Jamshidi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>No.45, Allame Shomali, 18th St., Saadatabad</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1997988435</zip>
        <telephone>+98 21 2206 0674</telephone>
        <email>sadegh.jamshidi@yahoo.com</email>
        <affiliation>Shahid Beheshti University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Patients who had history or signs of constipation  due to dyssynergia which were confirmed by anorectal maometery</inclusion_criteria>
      <agemin>15 years</agemin>
      <agemax>85 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Patients who had constipation due to secondary causes such as using opioids, endocrine diseases, neurologic diseases, history of surgery, etc.</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code></hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword></hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Drugs</i_code>
      <i_code>Treatment - Drugs</i_code>
      <i_code>Rehabilitation</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: First group: Patients who are assigned to do biofeedback exercises and also receive 15 grams of psyllium powder twice daily for three weeks.</i_keyword>
      <i_keyword>Intervention group: Second group:Patients who are assigned to do biofeedback exercises and also receive 10 grams of polethylene glycol twice daily for three weeks.</i_keyword>
      <i_keyword>Control group:Patients who are assigned to do biofeedback exercises. Each patient receives one session of education which takes 1.5 hours. They will be taught relaxation of anal sphincter, better sensation of defecation and rectoanal coordination by rectal probe.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Wellbeing by patient. Timepoint: in the beginning of study and three weeks after treatment. Method of measurement: asking the patient.</prim_outcome>
      <prim_outcome>Medication use to evacuation. Timepoint: in the beginning of study and three weeks after treatment. Method of measurement: asking the patient.</prim_outcome>
      <prim_outcome>Digitation to evacuate. Timepoint: in the beginning of study and three weeks after treatment. Method of measurement: asking the patient.</prim_outcome>
      <prim_outcome>Difficulties to evacuate. Timepoint: in the beginning of study and three weeks after treatment. Method of measurement: asking the patient.</prim_outcome>
      <prim_outcome>Return to toilet to evacuate. Timepoint: in the beginning of study and three weeks after treatment. Method of measurement: asking the patient.</prim_outcome>
      <prim_outcome>Feeling of incomplete evacuation. Timepoint: in the beginning of study and three weeks after treatment. Method of measurement: asking the patient.</prim_outcome>
      <prim_outcome>Straining to evacuate. Timepoint: in the beginning of study and three weeks after treatment. Method of measurement: asking the patient.</prim_outcome>
      <prim_outcome>Time needed to evacuate. Timepoint: in the beginning of study and three weeks after treatment. Method of measurement: asking the patient.</prim_outcome>
      <prim_outcome>Life style alteration. Timepoint: in the beginning of study and three weeks after treatment. Method of measurement: asking the patient.</prim_outcome>
      <prim_outcome>Rectal bleeding. Timepoint: in the beginning of study and three weeks after treatment. Method of measurement: asking the patient.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Shahid Beheshti University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2018-05-05</approval_date>
        <contact_name>Ethics committee of Shahid Beheshti university of medical sciences</contact_name>
        <contact_address>No. 45, West 18th Ave., Allame Shomali Blvd., Saadatabad Tehran Tehran Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
